Arkin Capital is a multi-stage investment firm managing over $2 billion. Initially focused on health and life sciences, particularly biotech, it has expanded into technology, sustainability, private equity, and real estate. The firm invests across early-stage to pre-IPO opportunities, leveraging expertise in each sector. Its portfolio includes a range of funds and sectors, with a consistent approach to backing ventures in areas with proven growth potential. Arkin Tech makes direct investments in tech companies.